D. U. Bawankule, et al., “BAY 41-2272 [5-Cyclopropyl2-[1-(2-fluoro-benzyl)-1H-pyrazolo[3,4-b]pyridine-3-yl]pyrimidin-4-ylamine]-Induced Dilation in Ovine Pulmonary Artery: Role of Sodium Pump,” Journal of Pharmacology and Experimental Therapeutics, Vol. 314, No. 1, 2005, pp. 207-213. http://dx.doi.org/10.1124/jpet.105.083824

has been cited by the following article:

• TITLE: Docking Studies, Synthesis, and Evaluation of Antioxidant Activities of N-Alkylated, 1,2,4-Triazole, 1,3,4-Oxa-, and Thiadiazole Containing the Aminopyrazolopyridine Derivatives

  AUTHORS: Yasser K. Abdelmonem, Farag A. El-Essawy, Saeda A. Abou El-Enein, Mona M. El-Sheikh-Amer

  KEYWORDS: Pyrazolopyridine; Biologically Active; Molecular Modeling and Inhibitor

  JOURNAL NAME: International Journal of Organic Chemistry, Vol.3 No.3, September 24, 2013

  ABSTRACT: Synthesis of some 1,3,4-thia-, oxa-diazol and 1,2,4 triazole incorporated the biologically active and the pyrazolopyri-dine derivative. Molecular modeling and docking of the active compounds into AKR1C3 complexed with its bound inhibitor indomethacin using Molsoft ICM 3.4-8C program were performed in order to predict the affinity and orientation of the synthesized compounds at the active site.